Postdoctoral Research Associate in Pharmacoepidemiology

The final salary offer may be determined by several factors, including, but not limited to, the candidate's qualifications, experience, and expertise, and availability of department or grant funds to support the position. We also take into consideration market benchmarks, if and when appropriate, and internal equity to ensure fair compensation relative to the university's broader compensation structure. We are committed to offering competitive and flexible compensation packages to attract and retain top talent.

Rutgers provides a comprehensive benefits package to eligible employees. The specific benefits vary based on the position and may include:

The fellow will work with Dr. Vincent Lo Re, Professor of Medicine in the Robert Wood Johnson Medical School and Director of the Rutgers Pharmacoepidemiology and Treatment Science ( PETS) Center and other faculty in the PETS Center. The successful Postdoctoral Research Associate candidate will further develop research skills under the mentorship of Dr. Lo Re through contributing to NIH and other HHS-funded research in the areas of pharmacoepidemiology, medical devices, and use of real-world data. The Postdoctoral Research Fellow will lead impactful research studies focusing on medical devices, lead the drafting and implementation of research protocols, publish in scientific journals, and have opportunities to present methods and research findings. The Postdoctoral Research Fellow would be expected to participate in regular research team meetings, relevant national and international research conferences, and lead the preparation of high-quality original research manuscripts. This is , with a possible extension based on funding availability and performance.

PETS was formed to create an interdisciplinary locus for world-class research and training in pharmacoepidemiology at Rutgers. Over the past 9 years, PETS has developed into a major research center, recruiting numerous core, affiliate, and adjunct faculty, and has accrued a highly experienced team of highly trained administrative and analytic staff. The current PETS Center core faculty have been funded by numerous R01s, K awards, and research foundation awards. PETS Center faculty work on a variety of topics in pharmacoepidemiology and related fields, including traditional medical product safety studies, comparative effectiveness research, pharmacoepidemiologic methods, clinical epidemiology, and health services research. They regularly collaborate with researchers across campus, across the US, and internationally, including colleagues from academia, industry, and government. Center faculty and trainees have access to a variety of national electronic health record-based and claims-based real-world data sources. PETS faculty members serve on US FDA Advisory Committees; study sections at the National Institutes of Health; committees at the National Academies of Science, Engineering, and Medicine; and in various roles within clinical and research organizations, particularly the International Society for Pharmacoepidemiology, where PETS Center faculty serve in numerous leadership roles.

The Rutgers Pharmacoepidemiology and Treatment Science ( PETS) Center (located within the Rutgers Institute for Health, Healthcare Policy and Aging Research) leads, performs, and facilitates innovative, multidisciplinary science related to the use, safety, and effectiveness of medical products (i.e., drugs, biologics, devices, vaccines) and medical interventions in populations. The Rutgers PETS Center vision is to improve the health of populations by producing actionable evidence on the need, use, safety, and effectiveness of interventions and medical products. The PETS Center pursues its vision through three interconnected missions: 1) Advance rigorous, high-impact research on interventions and medical products across populations, 2) Develop the next generation of scholars and leaders in pharmacoepidemiology and treatment science through rigorous training and transformative mentoring, and 3) Build a culture of collaboration and support that empowers our team to thrive and reach their full potential. Researchers within the PETS Center have great depth of expertise and experience in the analysis of Medicaid, Medicare, and private insurance data and the application of social science theory and advanced statistical techniques in large data sets.

The PETS Center builds on strong existing faculty and research infrastructure and enjoys substantial support from Rutgers Biomedical and Health Science ( RBHS). RBHS was created during the 2013 integration of the health professional schools from Rutgers University and the former University of Medicine and Dentistry of New Jersey. The eight schools, six centers and institutes and a behavioral health care network of RBHS collectively comprise one of America's largest, most comprehensive university-based centers for studying and improving human health and health care. The Institute for Health, RBHS, and the substantial resources of Rutgers University offer a rich collaborative environment for conducting pharmacoepidemiology and health services research. RBHS partners with RWJBarnabas Health, the state's largest healthcare delivery system. Research among these units expands considerably the opportunities for researchers. The Institute for Health, Healthcare Policy and Aging Research has faculty and other researchers with considerable expertise in pharmacoepidemiology the social and clinical sciences, health research and policy, public health, and related fields. Its faculty have exceptional capacity to address the most pressing health and healthcare challenges. Considerable strength exists in the analysis of large, integrated health-related clinical and administrative datasets, national surveys, and other data.